MXPA05007310A - Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoartrosis. - Google Patents

Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoartrosis.

Info

Publication number
MXPA05007310A
MXPA05007310A MXPA05007310A MXPA05007310A MXPA05007310A MX PA05007310 A MXPA05007310 A MX PA05007310A MX PA05007310 A MXPA05007310 A MX PA05007310A MX PA05007310 A MXPA05007310 A MX PA05007310A MX PA05007310 A MXPA05007310 A MX PA05007310A
Authority
MX
Mexico
Prior art keywords
bradykinin
receptor antagonists
osteoarthrosis
diseases
treating osteoarthrosis
Prior art date
Application number
MXPA05007310A
Other languages
English (en)
Inventor
Michaelis Martin
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MXPA05007310A publication Critical patent/MXPA05007310A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los peptidos que tienen accion antagonista de la bradiquinina son adecuados para la produccion de farmacos para la profilaxis y terapia de enfermedades en cuyo desarrollo esta involucrada una actividad incrementada de las metaloproteinasas de la matriz. Estas enfermedades incluyen enfermedades degenerativas de las articulaciones, por ejemplo osteoartrosis, espondilosis y condroporosis despues de traumatismo articular o inmovilizacion relativamente larga de una articulacion despues de lesiones de menisco o roturas de ligamentos.
MXPA05007310A 2003-02-07 2004-01-23 Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoartrosis. MXPA05007310A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10304994A DE10304994A1 (de) 2003-02-07 2003-02-07 Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
PCT/EP2004/000550 WO2004069266A2 (de) 2003-02-07 2004-01-23 Die verwendung von antagonisten des bradykinin-b2 rezeptors zur behandlung von osteoarthrose

Publications (1)

Publication Number Publication Date
MXPA05007310A true MXPA05007310A (es) 2005-09-30

Family

ID=32797325

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05007310A MXPA05007310A (es) 2003-02-07 2004-01-23 Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoartrosis.

Country Status (31)

Country Link
EP (1) EP1594520B1 (es)
JP (1) JP2006516980A (es)
KR (1) KR20050105447A (es)
CN (1) CN1317029C (es)
AR (1) AR043036A1 (es)
AT (1) ATE335500T1 (es)
AU (1) AU2004210396A1 (es)
BR (1) BRPI0407333A (es)
CA (1) CA2514152C (es)
CO (1) CO5690613A2 (es)
CY (1) CY1105708T1 (es)
DE (2) DE10304994A1 (es)
DK (1) DK1594520T3 (es)
ES (1) ES2268622T3 (es)
HK (1) HK1085926A1 (es)
HR (1) HRP20050701B1 (es)
IL (1) IL169899A0 (es)
MA (1) MA27618A1 (es)
ME (1) MEP41008A (es)
MX (1) MXPA05007310A (es)
MY (1) MY135827A (es)
NO (1) NO333903B1 (es)
NZ (1) NZ541680A (es)
PE (1) PE20040939A1 (es)
PL (1) PL206412B1 (es)
PT (1) PT1594520E (es)
RS (1) RS51029B (es)
RU (1) RU2329057C2 (es)
TW (1) TW200505472A (es)
WO (1) WO2004069266A2 (es)
ZA (1) ZA200505177B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710522D0 (en) * 2007-06-01 2007-07-11 Royal Veterinary College The Drug delivery system comprising matrix metalloproteinase inhibitors
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
FR2751650B1 (fr) * 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
CA2364178C (en) * 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
CA2474645C (en) * 2002-02-01 2011-08-09 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation

Also Published As

Publication number Publication date
NO333903B1 (no) 2013-10-14
AR043036A1 (es) 2005-07-13
HK1085926A1 (en) 2006-09-08
BRPI0407333A (pt) 2006-01-10
ZA200505177B (en) 2006-11-29
DE502004001159D1 (de) 2006-09-21
MA27618A1 (fr) 2005-11-01
RS20050565A (en) 2007-09-21
EP1594520A2 (de) 2005-11-16
ES2268622T3 (es) 2007-03-16
CN1747742A (zh) 2006-03-15
ATE335500T1 (de) 2006-09-15
CA2514152C (en) 2012-01-17
PL376605A1 (pl) 2006-01-09
CN1317029C (zh) 2007-05-23
TW200505472A (en) 2005-02-16
IL169899A0 (en) 2011-08-01
PL206412B1 (pl) 2010-08-31
CA2514152A1 (en) 2004-08-19
JP2006516980A (ja) 2006-07-13
AU2004210396A1 (en) 2004-08-19
NO20054144L (no) 2005-09-06
RU2005127862A (ru) 2006-01-27
DE10304994A1 (de) 2004-09-02
HRP20050701A2 (en) 2006-09-30
HRP20050701B1 (hr) 2014-01-03
DK1594520T3 (da) 2006-12-11
WO2004069266A2 (de) 2004-08-19
MY135827A (en) 2008-07-31
CO5690613A2 (es) 2006-10-31
CY1105708T1 (el) 2010-12-22
MEP41008A (en) 2011-02-10
EP1594520B1 (de) 2006-08-09
WO2004069266A3 (de) 2004-09-30
PT1594520E (pt) 2006-11-30
RS51029B (sr) 2010-10-31
PE20040939A1 (es) 2005-01-17
RU2329057C2 (ru) 2008-07-20
NZ541680A (en) 2009-07-31
KR20050105447A (ko) 2005-11-04

Similar Documents

Publication Publication Date Title
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
DE602004024043D1 (de) Knochenfraktur-fixationssystem mit subchondraler und artikulärer oberflächenunterstützung
MX9400287A (es) Procedimiento para la preparacion de un medicamento util para el tratamiento de la enfermedad de parkinson
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
ES2113635T3 (es) Aplicacion del riluzole en el tratamiento de lesiones neurologicas relacionadas con traumatismos.
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
WO2005000161A3 (en) Methods and devices for occluding body lumens and/or for delivering therapeutic agents
EP1830753A4 (en) REPLACEMENT OF JOINT FACETS
WO2004019884A3 (en) Agents and methods for enhancing bone formation
EP1422240A3 (en) Analogs of nociceptin
MXPA05007310A (es) Uso de antagonistas del receptor b2 de bradiquinina para el tratamiento de la osteoartrosis.
WO2004028453A3 (en) Methods for preventing and treating obesity in patients with mc4 receptor mutations
WO2004087905A3 (en) Protein tyrosine phosphatase and inhibitors thereof
ATE465740T1 (de) Stickstoffmonoxid-donorverbindungen auf hormongrundlage und deren verwendung in der geburtshilfe und gynäkologie
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
SE9802119D0 (sv) New use
BR0203025A (pt) dispositivo de tração aplicado com fins terapêuticos para tratamento fìsico de hérnias cervicais, lombares e demais problemas localizados na região cervical e lombar
DOP2003000657A (es) Amidas de acidos 2-heteroarilcarboxilicos
UA38037A (uk) Спосіб визначення уражень структур блукаючого нерва при абдомінальній патології

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration